F
FDA
Guest
FDA grants accelerated approval to mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...